Top Key Companies for Mammalian Cell Culture Service Market: Cell Culture Company, Novartis, Nordmark Pharma GmbH, ARVYS Proteins, Inc., Xell AG, BioXpedia, Biocompare, Sphere Fluidics, Huakan Bio, ABS Inc, Coriell Institute, BiBo Biopharma Engineering Co., LTD., Aurelia Bioscience, Rockland, Penn Genetics, Ningbo Mingzhou Biotechnology Co., Ltd., Lonza, FUJIFILM Diosynth Biotechnologies, Shanghai Sunway Biotech, Lerner Research Institute, Cell Biologics.
Global Mammalian Cell Culture Service Market Size was estimated at USD 392.1 million in 2022 and is projected to reach USD 650.38 million by 2028, exhibiting a CAGR of 8.8% during the forecast period.
Global Mammalian Cell Culture Service Market Overview And Scope:
The Global Mammalian Cell Culture Service Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Mammalian Cell Culture Service utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Mammalian Cell Culture Service Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mammalian Cell Culture Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mammalian Cell Culture Service market.
Global Mammalian Cell Culture Service Market Segmentation
By Type, Mammalian Cell Culture Service market has been segmented into:
Primary Cells
Transformed Cells
Self-renewing Cells
By Application, Mammalian Cell Culture Service market has been segmented into:
Production of Vaccines
Production of Monoclonal Antibodies
Production of Therapeutic Proteins
Others
Regional Analysis of Mammalian Cell Culture Service Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Mammalian Cell Culture Service Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Mammalian Cell Culture Service market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Mammalian Cell Culture Service market.
Top Key Companies Covered in Mammalian Cell Culture Service market are:
Cell Culture Company
Novartis
Nordmark Pharma GmbH
ARVYS Proteins
Inc.
Xell AG
BioXpedia
Biocompare
Sphere Fluidics
Huakan Bio
ABS Inc
Coriell Institute
BiBo Biopharma Engineering Co.
LTD.
Aurelia Bioscience
Rockland
Penn Genetics
Ningbo Mingzhou Biotechnology Co.
Ltd.
Lonza
FUJIFILM Diosynth Biotechnologies
Shanghai Sunway Biotech
Lerner Research Institute
Cell Biologics
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Mammalian Cell Culture Service Market by Type
5.1 Mammalian Cell Culture Service Market Overview Snapshot and Growth Engine
5.2 Mammalian Cell Culture Service Market Overview
5.3 Primary Cells
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Primary Cells: Geographic Segmentation
5.4 Transformed Cells
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Transformed Cells: Geographic Segmentation
5.5 Self-renewing Cells
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Self-renewing Cells: Geographic Segmentation
Chapter 6: Mammalian Cell Culture Service Market by Application
6.1 Mammalian Cell Culture Service Market Overview Snapshot and Growth Engine
6.2 Mammalian Cell Culture Service Market Overview
6.3 Production of Vaccines
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Production of Vaccines: Geographic Segmentation
6.4 Production of Monoclonal Antibodies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Production of Monoclonal Antibodies: Geographic Segmentation
6.5 Production of Therapeutic Proteins
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Production of Therapeutic Proteins: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Mammalian Cell Culture Service Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mammalian Cell Culture Service Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Mammalian Cell Culture Service Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CELL CULTURE COMPANY
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NOVARTIS
7.4 NORDMARK PHARMA GMBH
7.5 ARVYS PROTEINS
7.6 INC.
7.7 XELL AG
7.8 BIOXPEDIA
7.9 BIOCOMPARE
7.10 SPHERE FLUIDICS
7.11 HUAKAN BIO
7.12 ABS INC
7.13 CORIELL INSTITUTE
7.14 BIBO BIOPHARMA ENGINEERING CO.
7.15 LTD.
7.16 AURELIA BIOSCIENCE
7.17 ROCKLAND
7.18 PENN GENETICS
7.19 NINGBO MINGZHOU BIOTECHNOLOGY CO.
7.20 LTD.
7.21 LONZA
7.22 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
7.23 SHANGHAI SUNWAY BIOTECH
7.24 LERNER RESEARCH INSTITUTE
7.25 CELL BIOLOGICS
Chapter 8: Global Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Primary Cells
8.2.2 Transformed Cells
8.2.3 Self-renewing Cells
8.3 Historic and Forecasted Market Size By Application
8.3.1 Production of Vaccines
8.3.2 Production of Monoclonal Antibodies
8.3.3 Production of Therapeutic Proteins
8.3.4 Others
Chapter 9: North America Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Primary Cells
9.4.2 Transformed Cells
9.4.3 Self-renewing Cells
9.5 Historic and Forecasted Market Size By Application
9.5.1 Production of Vaccines
9.5.2 Production of Monoclonal Antibodies
9.5.3 Production of Therapeutic Proteins
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Primary Cells
10.4.2 Transformed Cells
10.4.3 Self-renewing Cells
10.5 Historic and Forecasted Market Size By Application
10.5.1 Production of Vaccines
10.5.2 Production of Monoclonal Antibodies
10.5.3 Production of Therapeutic Proteins
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Primary Cells
11.4.2 Transformed Cells
11.4.3 Self-renewing Cells
11.5 Historic and Forecasted Market Size By Application
11.5.1 Production of Vaccines
11.5.2 Production of Monoclonal Antibodies
11.5.3 Production of Therapeutic Proteins
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Primary Cells
12.4.2 Transformed Cells
12.4.3 Self-renewing Cells
12.5 Historic and Forecasted Market Size By Application
12.5.1 Production of Vaccines
12.5.2 Production of Monoclonal Antibodies
12.5.3 Production of Therapeutic Proteins
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Primary Cells
13.4.2 Transformed Cells
13.4.3 Self-renewing Cells
13.5 Historic and Forecasted Market Size By Application
13.5.1 Production of Vaccines
13.5.2 Production of Monoclonal Antibodies
13.5.3 Production of Therapeutic Proteins
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Mammalian Cell Culture Service Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Primary Cells
14.4.2 Transformed Cells
14.4.3 Self-renewing Cells
14.5 Historic and Forecasted Market Size By Application
14.5.1 Production of Vaccines
14.5.2 Production of Monoclonal Antibodies
14.5.3 Production of Therapeutic Proteins
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Mammalian Cell Culture Service Scope:
|
Report Data
|
Mammalian Cell Culture Service Market
|
|
Mammalian Cell Culture Service Market Size in 2025
|
USD XX million
|
|
Mammalian Cell Culture Service CAGR 2025 - 2032
|
XX%
|
|
Mammalian Cell Culture Service Base Year
|
2024
|
|
Mammalian Cell Culture Service Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Cell Culture Company, Novartis, Nordmark Pharma GmbH, ARVYS Proteins, Inc., Xell AG, BioXpedia, Biocompare, Sphere Fluidics, Huakan Bio, ABS Inc, Coriell Institute, BiBo Biopharma Engineering Co., LTD., Aurelia Bioscience, Rockland, Penn Genetics, Ningbo Mingzhou Biotechnology Co., Ltd., Lonza, FUJIFILM Diosynth Biotechnologies, Shanghai Sunway Biotech, Lerner Research Institute, Cell Biologics.
|
|
Key Segments
|
By Type
Primary Cells
Transformed Cells
Self-renewing Cells
By Applications
Production of Vaccines
Production of Monoclonal Antibodies
Production of Therapeutic Proteins
Others
|
